Search research articles
Contact Us
Filters
Showing results (11-20 of 71) with videos related to
Page
of 8
Sort By:
Expert Opinion on Therapeutic Patents
|
January 7, 2014
Aminothienopyridazines as imaging probes of tau pathology: a patent evaluation of WO2013090497
Carlo Ballatore, Amos B Smith, Virginia M-Y Lee, et al.
ACS Chemical Neuroscience
|
January 19, 2017
Non-Naturally Occurring Small Molecule Microtubule-Stabilizing Agents: A Potential Tactic for CNS-Directed Therapies
Carlo Ballatore, Kurt R Brunden, John Q Trojanowski, et al.
Biochemical Society Transactions
|
July 24, 2012
Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies
Kurt R Brunden, Carlo Ballatore, Virginia M-Y Lee, et al.
Bioorganic & Medicinal Chemistry
|
January 18, 2014
Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease
Kurt R Brunden, John Q Trojanowski, Amos B Smith, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 26, 2005
The design, synthesis, and evaluation of two universal doxorubicin-linkers: preparation of conjugates that retain topoisomerase II activity
Chengzao Sun, Simon E Aspland, Carlo Ballatore, et al.
Neurobiology of Disease
|
December 26, 2016
Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs
Kurt R Brunden, Virginia M-Y Lee, Amos B Smith, et al.
European Journal of Medicinal Chemistry
|
April 6, 2021
Structure property relationships of N-acylsulfonamides and related bioisosteres
Karol R Francisco, Carmine Varricchio, Thomas J Paniak, et al.
ACS Omega
|
October 25, 2019
Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant
Ittipat Meewan, Xingquan Zhang, Suchismita Roy, et al.
Experimental Neurology
|
September 12, 2009
Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors
Kurt R Brunden, Carlo Ballatore, Alex Crowe, et al.
Plos One
|
March 10, 2025
Kaempferia parviflora extract and its methoxyflavones as potential anti-Alzheimer assessing in vitro, integrated computational approach, and in vivo impact on behaviour in scopolamine-induced amnesic mice
Pitchayakarn Takomthong, Pornthip Waiwut, Chavi Yenjai, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 71) with videos related to
Sort By:
Page
of 8
Expert Opinion on Therapeutic Patents
|
January 7, 2014
Aminothienopyridazines as imaging probes of tau pathology: a patent evaluation of WO2013090497
Carlo Ballatore, Amos B Smith, Virginia M-Y Lee, et al.
ACS Chemical Neuroscience
|
January 19, 2017
Non-Naturally Occurring Small Molecule Microtubule-Stabilizing Agents: A Potential Tactic for CNS-Directed Therapies
Carlo Ballatore, Kurt R Brunden, John Q Trojanowski, et al.
Biochemical Society Transactions
|
July 24, 2012
Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies
Kurt R Brunden, Carlo Ballatore, Virginia M-Y Lee, et al.
Bioorganic & Medicinal Chemistry
|
January 18, 2014
Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease
Kurt R Brunden, John Q Trojanowski, Amos B Smith, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 26, 2005
The design, synthesis, and evaluation of two universal doxorubicin-linkers: preparation of conjugates that retain topoisomerase II activity
Chengzao Sun, Simon E Aspland, Carlo Ballatore, et al.
Neurobiology of Disease
|
December 26, 2016
Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs
Kurt R Brunden, Virginia M-Y Lee, Amos B Smith, et al.
European Journal of Medicinal Chemistry
|
April 6, 2021
Structure property relationships of N-acylsulfonamides and related bioisosteres
Karol R Francisco, Carmine Varricchio, Thomas J Paniak, et al.
ACS Omega
|
October 25, 2019
Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant
Ittipat Meewan, Xingquan Zhang, Suchismita Roy, et al.
Experimental Neurology
|
September 12, 2009
Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors
Kurt R Brunden, Carlo Ballatore, Alex Crowe, et al.
Plos One
|
March 10, 2025
Kaempferia parviflora extract and its methoxyflavones as potential anti-Alzheimer assessing in vitro, integrated computational approach, and in vivo impact on behaviour in scopolamine-induced amnesic mice
Pitchayakarn Takomthong, Pornthip Waiwut, Chavi Yenjai, et al.
Page
of 8